It is important to determine whether the epigenomic landscape is affected by alterations in the ARID1A SWI/SNF complex at different stages of endometrial tumor development or in response to endogenous and exogenous factors such as hormones, obesity, and exposure to infection or carcinogen. The gene discussed is ARID1A; the disease is endometrium neoplasm.